May 17, 2024

Bringing you the latest in health and wellness, 24/7

Clinic News
MedTech Devices
Health Tech Developments
Pharmaceuticals Spotlight
Emotional Wellness
Virus Scope
Authored Articles

Search for:

Home
Joe Vogel

Joe Vogel

Hemab Therapeutics Presents Positive Phase 1 Results for HMB-001 in Glanzmann Thrombasthenia at 2024 EAHAD Annual Congress

2 min read

Hemab Therapeutics Presents Positive Phase 1 Results for HMB-001 in Glanzmann Thrombasthenia at 2024 EAHAD Annual Congress

Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders,...

Hemab Therapeutics Presents Positive Phase 1 Results for HMB-001 in Glanzmann Thrombasthenia at 2024 EAHAD Annual Congress

Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders,...

Recent Posts

TOP PMR SPECIALIST DR. AASTIK BHATT JOINS HCAH
1 IN 6 INDIVIDUALS STRUGGLE WITH INFERTILITY
Exactech Enhances High Technology Knee System with New Balancing Software
BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000
Introducing Ignians’ Total Multivitamin & Sleep Aid Capsules: The Ultimate Solution for High Performers

You may have missed

TOP PMR SPECIALIST DR. AASTIK BHATT JOINS HCAH

3 min read

TOP PMR SPECIALIST DR. AASTIK BHATT JOINS HCAH

May 15, 2024

1 IN 6 INDIVIDUALS STRUGGLE WITH INFERTILITY

2 min read

1 IN 6 INDIVIDUALS STRUGGLE WITH INFERTILITY

May 14, 2024

Exactech Enhances High Technology Knee System with New Balancing Software

Exactech Ligament-Driven Balancing TechnologyExactech Ligament-Driven Balancing Technology

2 min read

Exactech Enhances High Technology Knee System with New Balancing Software

May 13, 2024

BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000

BGI-Heilongjiang Omics Health Axis Intelligent Laboratory

2 min read

BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000

May 13, 2024

Contact Us
Privacy Policy
Disclaimer
Terms and Conditions
About Us
Careers
Advertise with us
Sitemap

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Powered by GDPR Cookie Compliance

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Hemab Therapeutics Presents Positive Phase 1 Results for HMB-001 in Glanzmann Thrombasthenia at 2024 EAHAD Annual Congress

Hemab Therapeutics Presents Positive Phase 1 Results for HMB-001 in Glanzmann Thrombasthenia at 2024 EAHAD Annual Congress

You may have missed

TOP PMR SPECIALIST DR. AASTIK BHATT JOINS HCAH

1 IN 6 INDIVIDUALS STRUGGLE WITH INFERTILITY

Exactech Enhances High Technology Knee System with New Balancing Software

BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000￼

BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000